CRLCharles River LaboratoriesHealth Care
$291.50EarningsNov 4, 2026
1D—1W—1M—3M—1Y—
Market cap$14.3BCompany infoRevenue$4.0B52-wk range$146 – $299IndustryMedical - Diagnostics & ResearchWebsitecriver.comRelated
Market Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▲ +85.7% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E———
P / S3.5×4051
2
7
P / FCF36.5×2122
13
52
EV / EBITDA21.3×2637
12
31
P / E (fwd)25.8×——
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin31.9%2721
32%
38%
Operating margin11.8%3739
3%
18%
Net margin-4.6%714
-5%
12%
ROE-5.8%817
-6%
18%
ROIC6.2%3438
2%
10%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity1.043222
0.6
1.2
Net debt / EBITDA3.6×2416
Current ratio1.364924
Interest coverage4.5×4036
Per shareTTM, with year-over-year change
Revenue / share$82.27▲ +0%
EPS (diluted)$-3.76▼ −478%
FCF / share$7.99▼ −31%
Est. EPS growth (fwd)+12%